Retinal Pigment Epithelium Tear After Intravitreal Bevacizumab in Pigment Epithelium Detachment

Purpoe To evaluate pigment epithelium detachment (PED) econdary to exudative age-related macular degeneration (AMD) treated with intravitreal injection of bevacizumab with regard to incidence of retinal pigment epithelium tear (RIP). Deign Retropective, interventional cae erie. Method Intitutional tudy of 31 eye with PED in exudative AMD receiving intravitreal bevacizumab. Main outcome meaure were Early Treatment of Diabetic Retinopathy tudy (ETDR) viual acuity, PED vacularization and ize meaured by angiography and optical coherence tomography (OCT) imaging, and incidence of RIP. Reult Viion improved in ix eye and remained table in 22 eye (follow-up, 12.3 ± 10.3 week). Twenty-eight eye howed a vacularized PED. Four eye (12.9%) experienced an RIP without viion lo. All RIP cae were vacularized in more than 50% of total leion ize. Concluion In hort-term follow-up, the rik for RIP after bevacizumab injection in eye with PED eem to be moderately, but not tatitically ignificantly, increaed in PED leion vacularized more than 50%.